Evotec (EVO) vs Helus Pharma (HELP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Helus Pharma (HELP) has outperformed Evotec (EVO) over the past year, gaining 9.3% versus a loss of 55.6%. Over five years, HELP leads with a -88.1% price change compared with -94.4% for EVO. Helus Pharma is the larger company by market cap ($487.7 million vs $469.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EVO | HELP |
|---|---|---|
| Share price | $1.32 | $6.11 |
| Market cap | $469.11M | $487.68M |
| 1-day change | -8.97% | -9.88% |
| YTD return | -57.14% | -25.31% |
| 1-year return | -55.56% | +9.30% |
| 5-year return | -94.44% | -88.09% |
| EPS (TTM) | $-0.59 | $-4.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.87 | $15.15 |
| 52-week low | $1.32 | $3.76 |
| Distance from 52-week high | -65.89% | -59.67% |
| Analyst consensus | buy | none |
| Avg. price target upside | +237.12% | +564.81% |
| Average volume | 109.16K | 1.83M |
| Shares outstanding | 355.39M | 79.81M |
| Employees | 4,379 | 100 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HELP has outperformed EVO by 64.9 percentage points over the past year.
About Evotec
EVO stock →Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biologics.
Health Care · Biotechnology: Pharmaceutical Preparations · 4,379 employees
About Helus Pharma
HELP stock →Helus Pharma Inc. operates as a clinical stage pharmaceutical company that focuses on developing therapies to treat psychiatric and neurological conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
EVO vs HELP FAQ
Which is bigger, Evotec or Helus Pharma?
Helus Pharma (HELP) is larger, with a market capitalization of $487.68M compared with $469.11M for Evotec (EVO).
Which stock has performed better over the past year, EVO or HELP?
HELP returned +9.30% over the past 12 months, compared with -55.56% for EVO (price return, excluding dividends). Past performance does not predict future results.
Are Evotec and Helus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.